OrbiMed Israel BioFund GP Limited Partnership's Net Worth

$5.24 Million

Estimate Recalculated Apr 15, 2024 06:29PM EST

Who is OrbiMed Israel BioFund GP Limited Partnership?

OrbiMed Israel BioFund GP Limited Partnership has an estimated net worth of $5.24 Million. This is based on reported shares across multiple companies, which include Adicet Bio, Inc., BiomX Inc., Chemomab Therapeutics Ltd., 9 METERS BIOPHARMA, INC., and Novus Therapeutics, Inc..

SEC CIK

OrbiMed Israel BioFund GP Limited Partnership's CIK is 0001569821

Past Insider Trading and Trends

2020 was OrbiMed Israel BioFund GP Limited Partnership's most active year for acquiring shares with 15 total transactions. OrbiMed Israel BioFund GP Limited Partnership's most active month to acquire stocks was the month of April. 2021 was OrbiMed Israel BioFund GP Limited Partnership's most active year for disposing of shares, totalling 3 transactions. OrbiMed Israel BioFund GP Limited Partnership's most active month to dispose stocks was the month of May. 2021 saw OrbiMed Israel BioFund GP Limited Partnership paying a total of $14,837,112.89 for 1,994,509 shares, this is the most they've acquired in one year. In 2021 OrbiMed Israel BioFund GP Limited Partnership cashed out on 17,150,781 shares for a total of $20,932,965.86, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

BiomX Inc. (PHGE) Snapshot price: $0.2197

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 15
Form 4
+12.37%
348K
$0.25
$85,260.00
3.16M
Feb 27
Form 4
+21.61%
500K
—
—
2.81M
Jul 28
Form 4
+0.17%
4K
$8.90
$35,615.00
2.31M
Dec 18 - Dec 19
Form 4
+0.38%
8.8K
$8.85
$77,918.00
2.31M
Dec 10 - Dec 11
Form 4
+0.45%
10.2K
$8.40
$85,646.00
2.3M
Dec 5 - Dec 9
Form 3
—
0
—
—
0
No matching records found

Adicet Bio, Inc. (ACET) Snapshot price: $3.21

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+47.01%
3.13M
$2.40
$7,500,000.00
9.77M
Jan 25
Form 4
+12.10%
875K
$2.09
$1,828,750.00
8.11M
Jun 27
Form 4
+765.30%
214.28K
$14.00
$2,999,990.00
242.28K
Dec 10
Form 4
+10.25%
524.35K
$13.00
$6,816,537.00
5.64M
Feb 12
Form 4
∞
6.02M
—
—
6.02M
Sep 15 - Sep 17
Form 3
—
0
—
—
0
No matching records found

Chemomab Therapeutics Ltd. (CMMB) Snapshot price: $0.59

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-13.07%
-336.90K
$3.58
-$1,207,759.08
2.24M
Jan 3
Form 3
—
0
—
—
0
Form 4
+12.58%
288.17K
$17.35
$4,999,749.50
2.58M
Mar 16
No matching records found

9 METERS BIOPHARMA, INC. (NMTRQ) Snapshot price: $0.000001

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-66.69%
-17.15M
$1.22
-$20,932,965.86
8.57M
Jun 23 - Jun 25
Form 4
+0.06%
31.94K
$0.66
$20,836.39
51.48M
May 11
Form 4/A
∞
18.93M
—
—
18.93M
Apr 30 - May 4
Form 4
+8.18%
1.94M
—
—
25.72M
Oct 30
Form 4
+39.95%
6.79M
—
—
23.77M
Jun 30
Form 4
—
0
—
—
0
May 4
Form 4
—
0
—
—
0
Apr 30
Form 3
—
0
—
—
0
No matching records found

Novus Therapeutics, Inc. (ELDN) Snapshot price: $1.9834

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-58.35%
-103.20K
$21.60
-$2,229,120.00
73.65K
Dec 2
Form 4
—
0
—
—
0
Jan 14
Form 4
+25.47%
646.2K
$3.10
$2,003,232.40
3.18M
May 2
Form 4
∞
2.54M
—
—
2.54M
May 9
Form 3
—
0
—
—
0
No matching records found